Brii Biosciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	656.26	489.65	1,191	2,855	1,035	880.36
Short-Term Investments	1,731	2,171	1,807	499.65	20	-
Cash & Short-Term Investments	2,387	2,661	2,997	3,355	1,055	880.36
Cash Growth	-12.86%	-11.23%	-10.65%	218.00%	19.83%	-
Other Receivables	-	71.09	57.72	51.52	24.8	2.89
Receivables	-	71.09	57.72	51.52	24.8	2.89
Other Current Assets	172.58	51.03	21.79	7.68	13.08	2.21
Total Current Assets	2,559	2,783	3,077	3,414	1,093	885.46
Property, Plant & Equipment	2.12	5.61	19.52	33.44	43.92	56.77
Long-Term Investments	23.12	142.44	146.03	152.03	116.55	94.88
Other Intangible Assets	268.88	267.42	146.89	9.51	12.22	-
Other Long-Term Assets	43.14	-	2.51	2.79	2.41	2.32
Total Assets	2,897	3,198	3,392	3,612	1,268	1,039
Accrued Expenses	35.04	68.63	150.87	205.83	486.67	16.75
Current Portion of Leases	1.1	3.16	9.5	8.97	8.02	8.07
Current Income Taxes Payable	1.62	2.01	1.86	1.65	1.02	0.53
Current Unearned Revenue	28.83	50.63	54.68	52.88	69.82	36.11
Other Current Liabilities	1.11	1.44	12.2	11.38	9.7	0.43
Total Current Liabilities	67.7	125.87	229.11	280.71	575.24	61.88
Long-Term Debt	-	-	-	-	2,403	1,535
Long-Term Leases	0.8	-	3.16	12.65	20.31	27.04
Long-Term Unearned Revenue	-	-	2.08	7.08	12.08	27.92
Total Liabilities	86.31	125.87	234.35	300.44	3,011	1,652
Common Stock	0.02	0.02	0.02	0.02	0.01	0.01
Additional Paid-In Capital	9,381	9,377	9,352	9,317	74.33	62.27
Retained Earnings	-6,978	-6,697	-6,522	-6,038	-1,874	-684.45
Treasury Stock	-0.07	-0.07	-	-	-	-
Comprehensive Income & Other	456.14	439.28	364.69	63.71	61.42	9.41
Total Common Equity	2,860	3,119	3,195	3,343	-1,738	-612.76
Minority Interest	-49.36	-46.66	-37.12	-31.65	-4.41	-
Shareholders' Equity	2,810	3,072	3,157	3,311	-1,743	-612.76
Total Liabilities & Equity	2,897	3,198	3,392	3,612	1,268	1,039
Total Debt	1.9	3.16	12.66	21.62	2,431	1,570
Net Cash (Debt)	2,385	2,658	2,985	3,333	-1,376	-690.1
Net Cash Growth	-12.67%	-10.96%	-10.45%	-	-	-
Net Cash Per Share	3.27	3.65	4.13	7.59	-7.20	-3.86
Filing Date Shares Outstanding	729.99	729.39	727.2	720.29	706.2	178.6
Total Common Shares Outstanding	729.99	729.39	727.2	720.29	108.65	178.6
Working Capital	2,492	2,657	2,848	3,133	517.61	823.57
Book Value Per Share	3.92	4.28	4.39	4.64	-16.00	-3.43
Tangible Book Value	2,591	2,852	3,048	3,333	-1,751	-612.76
Tangible Book Value Per Share	3.55	3.91	4.19	4.63	-16.11	-3.43
Machinery	-	0.34	0.34	0.34	0.34	0.34
Leasehold Improvements	-	24.84	24.84	24.84	23.81	23.81

Source: S&P Capital IQ. Standard template. Financial Sources.